Unidad de Gestión Clínica Área del Corazón, Hospital Universitario Virgen de la Victoria, Málaga, Spain. Instituto de investigación biomédica de Málaga (IBIMA-Plataforma BIONAND), Málaga, Spain
Case Report
Myopericarditis and pulmonary thrombosis after administration of the BNT162b2 vaccine against COVID-19 in a carrier of familial Mediterranean Fever
Author(s): Elisabeth Gomez Moyano, German Alegre-García*, Isabel Piñeiro Uribe, Beatriz Pérez-Villardón, Javier Mora-Robles and Manuel Jiménez-Navarro
Based on the current interest in the complications associated with vaccination against COVID-19, we present this case report of great interest
that shows a carrier of familial Mediterranean fever who suffered myopericarditis and pulmonary thrombosis after administration of the BNT162b2
vaccine against COVID-19.
Certain autoimmune disorders may be triggered by COVID-19 vaccination in genetically susceptible persons. A 40-year-old woman had a history
of deep vein thrombosis in 2006 coinciding with taking oral contraceptives, and a daughter with familial Mediterranean fever. In January 2021,
as part of the COVID-19 vaccination program, she received her first dose of the BNT162b2 vaccination. Thirteen hours after the second dose
she presented at the hospital with oppressive chest pain and fever and after several tests, including a cardiac MRI, she was diagnosed.. Read More»
DOI:
10.37421/2684-4915.2022.6.218
Clinical and Medical Case Reports received 40 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 